Balaji & Benedict Evans: When Tech Breaks Ind...

Christopher Mims and Tim Higgins of the Wall Street Journal sit down with a16z General Partner Martin Casado on WSJ’s Bold Names to ask whether the AI spending boom is a bubble waiting to burst. Martin explains why the fundamentals differ dramatically from the dot-com era—when Wo ...  Afficher plus

a16z general partner Erik Torenberg speaks with Justin Mares, founder and CEO of Truemed. They discuss why American health outcomes are so poor compared to the rest of the developed world, how crop subsidies created a food system that "systematically outputs unhealthy people," an ...  Afficher plus

Biotechnology is the use of biology in the production of new products, services, and organisms with the aim of improving human health and society. In 2024, the global biotech market was worth $1.68 trillion. By application, the health segment was responsible for just over half of ...  Afficher plus

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Afficher plus

This week, we’re presenting an episode of Climate Rising from our friends at Harvard Business School.  In this first episode of a new series on climate change and AI, Hamid Maher and Charlotte Degot, Managing Directors and Partners at Boston Consulting Group (BCG), explain how BC ...  Afficher plus

Never before has it been harder for leaders to make sense of what’s going on in the world. As exponential technologies like artificial intelligence (AI) march on, the ability to make future-proof decisions is all the more important for leaders.

Azeem Azhar’s</st ...